Back to top

Oncolytics announces FDA Fast Track designation for pelareorep

Oncolytics (ONCY) announced that the FDA has granted Fast Track designation to pelareorep in combination with a checkpoint inhibitor for the treatm...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Oncolytics Biotech Inc. (ONCY)